Gazyva (obinutuzumab)
Patient Assistance Program Guide — Genentech Patient Foundation
Do You Qualify?
Income
Up to $150,000 for a single person
Insurance
Patient must be uninsured, underinsured, or have government insurance (like Medicare) and meet financial criteria. Patients with commercial insurance that covers the drug are generally not eligible for the Foundation but may use the Co-pay Card.
Residency
Must live in the United States, District of Columbia, or a U.S. territory.
Income Limits by Household Size
Genentech Patient Foundation generally uses a flat income cap of $150,000 for oncology products regardless of household size.
# Getting Gazyva (Obinutuzumab) Through the Genentech Patient Foundation: A Complete Guide
---
Who Qualifies for the Genentech Patient Foundation?
If you need Gazyva (obinutuzumab) and cannot afford it, the Genentech Patient Foundation may be able to provide it to you at no cost. This program is designed specifically for patients who lack adequate insurance coverage or who meet certain financial criteria.
For a single-person household, the income limit is $150,000 per year. This threshold applies regardless of household size, which means most applicants will fall well within the limit.
To be eligible, you must be uninsured, underinsured, or covered by a government insurance program such as Medicare. Patients who have private commercial insurance that already covers Gazyva are generally not eligible for the Foundation program, though a separate savings card option may be available to them.
---
About Gazyva (Obinutuzumab)
Gazyva is a prescription medication made by Genentech. It is approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). It belongs to a class of drugs called CD20-directed cytolytic antibodies, meaning it targets a specific protein found on certain blood cells.
As a biologic infusion therapy, Gazyva is administered in a clinical setting and carries a high list price — often tens of thousands of dollars per treatment course. Without insurance or financial assistance, most patients would be unable to afford it. No FDA-approved biosimilar versions of Gazyva currently exist, which limits lower-cost alternatives at this time.
---
Income Eligibility: Full Breakdown
The Genentech Patient Foundation uses a flat income cap of $150,000 per year for Gazyva, regardless of how many people are in your household. Here is the full breakdown:
| Household Size | Maximum Annual Income |
|---|---|
| 1 person | $150,000 |
| 2 persons | $150,000 |
| 3 persons | $150,000 |
| 4 persons | $150,000 |
Because the threshold does not change based on household size, a family of four has the same income limit as a single individual. This is somewhat unusual compared to other assistance programs, but it works in your favor if you have a larger household.
Income is typically verified using your most recent federal tax return, W-2 forms, or three months of recent pay stubs. If your income has changed significantly since last year — for example, due to job loss or a reduction in hours — you may be able to use current pay stubs to reflect your actual situation.
If your income is above $150,000, you may not qualify for the Foundation program. However, you should still explore the alternatives listed later in this guide, including state pharmaceutical assistance programs and the Gazyva co-pay savings card.
---
Insurance Requirements Explained
Your insurance situation determines which pathway applies to you:
---
Step-by-Step: How to Apply
1. Gather your documents before you start. You will need: a completed application form (with sections filled out by both you and your prescriber), proof of income (most recent tax return, W-2, or pay stubs), and a current prescription for Gazyva.
2. Choose your application method. You can apply online, by phone, or by fax.
- Online: Visit https://www.genentechpatientfoundation.com/
- Phone: Call (888) 941-3331 to apply with a representative or ask questions
- Fax: Send completed forms to (877) 429-9827
3. Complete the patient section of the application. Provide your personal information, household size, income, insurance status, and signature.
4. Have your prescriber complete their section. Your doctor or their office staff must sign the prescriber portion of the form and include your Gazyva prescription. Many prescriber offices are familiar with this process and can help coordinate the submission.
5. Submit the application with all supporting documents. Missing documents are one of the most common reasons for delays, so double-check that everything is included before submitting.
6. Wait for a decision. Processing typically takes 2 to 3 business days after the Foundation receives a complete application.
7. Confirm approval with your prescriber's office. Once approved, notify your care team so they are ready to receive the medication shipment.
---
What to Expect: Timeline and Delivery
Once you submit a complete application, you can typically expect a decision within 2 to 3 business days. Approval notices are usually sent to the prescriber's office, so make sure your care team knows to watch for confirmation.
If approved, Gazyva is shipped directly to your prescriber's office or infusion center — not to your home. This is standard for infusion medications that require clinical administration. You do not need to pick up or transport the medication yourself.
Your approval through the Genentech Patient Foundation is not permanent. Annual reauthorization is required, meaning you will need to reapply roughly once a year to confirm that you still meet the eligibility criteria. Your prescriber's office or the Foundation will typically notify you when it is time to renew.
---
Alternatives If You Don't Qualify
If you do not qualify for the Genentech Patient Foundation, here are other options to explore:
Biosimilars: There are currently no FDA-approved biosimilar versions of Gazyva. This option is not available at this time.
Gazyva Co-pay Savings Card: If you have commercial insurance, you may be eligible for Genentech's co-pay card, which can reduce your out-of-pocket costs. Learn more and enroll at https://www.gazyva.com/cll/financial-support/co-pay-card.html.
State Pharmaceutical Assistance Programs (SPAPs): Many states run their own drug assistance programs, especially for Medicare beneficiaries. Eligibility and benefits vary by state. Ask your doctor's office or a social worker for programs in your area.
NeedyMeds.org: This free, nonprofit database at www.needymeds.org lists hundreds of assistance programs by drug name or condition. It is a useful starting point if other options have not worked out.
RX Advantages can also help you search for additional programs that may fit your situation.
---
*This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Genentech. Program terms may change — verify current requirements at [https://www.genentech-access.com/patient/brands/gazyva.html](https://www.genentech-access.com/patient/brands/gazyva.html) before applying.*
---
Documents You'll Need
If You Don't Qualify for the Assistance Program
Manufacturer Savings Card (for insured patients)
Genentech offers a savings card that may reduce your out-of-pocket cost if you have commercial insurance. Ask your prescriber or pharmacist for current savings card details.
Common Questions
Yes. The Genentech Patient Foundation accepts patients who have government insurance, including Medicare Part D. You will still need to meet the income requirement of $150,000 or less per year and complete the standard application. Call (888) 941-3331 if you have questions about how your specific Medicare plan affects eligibility.
Once the Foundation receives a complete application — including the prescriber section and proof of income — a decision is typically made within 2 to 3 business days. After approval, Gazyva is shipped directly to your prescriber's office or infusion center. Contact your care team to confirm they have received the shipment before your scheduled infusion.
Yes. The Genentech Patient Foundation requires annual reauthorization. You will need to reapply approximately once a year to confirm that you still meet the eligibility requirements. Your prescriber's office or the Foundation should notify you when it is time to renew. Starting the renewal process early helps avoid any gap in your medication supply.
If you have commercial insurance that covers Gazyva, you are generally not eligible for the Foundation program. However, you may qualify for the Gazyva Co-pay Savings Card, which can help reduce your out-of-pocket costs. Visit https://www.gazyva.com/cll/financial-support/co-pay-card.html to learn more and enroll.
Not at this time. There are currently no FDA-approved biosimilar versions of Gazyva (obinutuzumab). If cost remains a concern, speak with your doctor about whether any alternative treatments are appropriate for your condition, and explore assistance programs like the Genentech Patient Foundation or state pharmaceutical assistance programs.
Ready to Apply for Gazyva Assistance?
RX Advantages handles the entire Genentech Patient Foundation application on your behalf — paperwork, physician coordination, and refill tracking. It takes about 15 minutes to get started.
No SSN required on the web form · From $49.95/month